Labor induction Is often necessary because of maternal ar fetallndlcatlons. When performed with an unripe cervix, it results in prolonged labor, potential medical compliad:ions, and an increased rate of cesarean seclio:o. The purpose of cervk:aI ripening and induction of Iabar Is to achieve vaginal delivery and avoid operative delivery by cesarean section. In this revlew, we present cellular and biochemical events in cervk:aI ripeJling and discuss the indications and contralndlcatlons of labor l!IductIolI, and then describe various pharmacologic and mechanical methods for ripening the cerv:Ix and inducing labor.
cellular and Biochemical Events in cervical Ripening
Ripening ofthe cervix is complex, and our understanding of the physiologic mechanisms involved in cervical ripeoing Is far from complete. Cellular aspects of cervical maturation include presence of smooth muscle, collagen, and ground substance or connective tissue. Changes that take place in collagen and in the connective tissue matrix appear to be the primary factors in cervical ripening. Enzymes, hormones, and collagen breakdown by-products control these changes. While various hormones have been implicated in physiology ofcervical ripening, prostaglandins appear to play an important role.
Danforth et aI were the first to recognize that changes in the structure and biochemistry of connective tissue are key elements ofcervical ripening. 2 They demonstrated that during cervical ripening the ground substance becomes more prominent, and the collagen fibrils previously arranged in an orderly fashion break up. The collagen is embedded in a ground substance consisting of large molecular weight proteoglycan complexes containing a variety of substances called glycosaminoglycans. Chemically, glycosaminoglycans are long, negatively charged disaccharides that contain one hexosamine (glucosamine or galactosamine) and one uronic acid (glucuronic or iduronic). The structure ofcollagen is a helix of three collagen a chains of approxbnately 100,000 MW each. Several types of glycosaminoglycans are described, such as heparin, heparan sulfate, dermatan, and chondroitin sulfate. In the cervix, collagen fibrils of proteoglycans are attached by their protein core to glycosaminoglycan side chains and maintain the mechanical strength of the cervix.3~Although there is an increase in the total collagen content ofcervix at term, the collagen concentration is reduced by 30 in the tissue remodeling that occurs during cervical ripening," It is proposed that programmed cell death (apoptosis) may have a significant role in cervical ripening. 18 Undoubtedly, natural and synthetic prostaglandins playa role in cervical ripening. The main prostaglandins produced by the cervix are PGE2, PGI2, and, to a lesser extent, PGF2.19 Recently, a prostaglandin E1 analogue, misoprostol, has received increased attention as a highly effective cervical ripening agent."" Prostaglandin E2-mediated cervical ripening may be due to the breakdown of collagen tissue, alteration in glycosaminoglycans/proteoglycan content, or increased hyaluronic acid concentration, and cervical hydration.22-26
Clinically, estrogens such as estradiol have been used to produce cervical ripening.n-29
The ripening effects of estrogen on the cervix may be related to the induction of prostaglandin synthesis by estradiol that results in an influx of protease-producing leukocytes, which may be responsible for promoting cervical ripening. Unlike estrogen, progesterone appears to inhibit collagenase activity and also acts as a potent anti-inflammatory Based on original animal observations, it was postulated that relaxin, a 6-KD dimeric peptide hormone, plays a role in cervical maturation. 36 It has been suggested that relaxin increases collagenase activity in humans via a mitotic effect on fibroblasts." While the specific role of relaxin in human pregnancy is not clearly understood, there is evidence to support its role in cervical maturation and ripening.
RequIrements for induction
Ripening and induction of labor are indicated for a variety of maternal or fetal conditions when benefits either to the mother or to the fetus outweigh the benefits of continuing the pregnancy. The state of the cervix prior to induction of labor has tremendous impact on the outcome of the induction. The goal of induction of labor is to eliminate the potential risks to the fetus with prolonged intrauterine existence while minimizing the likelihood of an operative delivery. Induction of labor is the initiation of uterine contractions before the spontaneous + onset of labor. Induction is done by medical or surgical means to achieve delivery. Maternal and fetal risk benefit analysis should be assessed prior to induction oflabor. Before inducing labor, the physidan should assure there is an indication for induction, explain the induction procedure, and obtain an informed consent from the patient. A pediatrician should be notified so he can make spectfic plans for the management of the neonate. Maternal pelvic bony structures should be assessed for their adequacy for vaginal delivery. fetal weight and presentation should be determined. Most inductions are done at term, when fetal lung maturity is documented. However, the benefit of a premature delivery of a fetus from a hostile intrauterine environment may outweigh the potential risks associated with prematurity. Assessment of fetal lung maturity is often necessary prior to induction of labor. According to the American College of Obstetricians and Gynecologists, if one of the following criteria is met, fetal maturity may be assumed and amniocentesis need not be performed: 38 • fetal heart tones have been documented for 20 weeks by nonelectronic fetoscope or for 30 weeks by Doppler.
• It has been 36 weeks since a positive serum or urine human chorionic gonadotropin pregnancy test was performed by a reliable method.
• An ultrasound measurement of the crown-rump length, obtained at 6-11 weeks, supports a gesta- Methods ofcervtca1 Ripenlng and Labor Induction
Various methods and agents for cervical ripening and labor induction have been described in obstetrics literature. Table 2 The most common methods for cervical ripening and induction oflabor are surgical-stripping ofthe membranes and amniotomy -as well as medical approaches that include the use of oxytocin and prostaglandin preparations.
A. Stripping ofthe Membranes
Digital stripping of the membranes from the lower uterine segment has been used extensively as a clinical method for induction of labor. This method appears to release prostaglandins from the membranes and adjacent decidua and causes a rise in plasma concentrations of prostaglandins, which provides a possible explanation for initiation of uterine activity following sucb intervention." Membrane stripping is done digitally once daily for up to three days or once a week during pelvic examinations.
Risks associated with this technique include infection, bleeding from a previously undiagnosed placenta previa or low-lying placenta, and accidental rupture ofthe membranes.
One study indicated that membrane stripping may be associated with decreased incidence of postdate pregnancies. 54 duration of pregnancy and the need of labor induction. Despite the above studies, further larger ran-• domized trials are needed to confirm efficacy and safety of membrane stripping before it is used routinely for induction.
B. Amniotomy
Artificial rupture of the fetal membranes, or amniolomy, is a commonly employed method of labor induction, especially when used in conjunction with oxytocin infusion. Routine amniotomy is reported to result in modest reduction in duration of labor. 57 However, when it is used in combination with oxytocin infusion, it significantly shortens the interval from induction to delivery.58 In women with a ripe cervix and ahigh Bishop score, amniotomy has been reported to be 88% successful in inducing labor." Ideally, amniotomy is performed when the cervix is favorable. In urgent situations when induction oflabor needs to be done as soon as possible, i.e. severe preeclampsia, this procedure can be done with minimal cervical dilation if the presenting part is well applied to the cervix. Thus the risk of a cord prolapse can be avoided. neys. Furthermore. oxytocinase, a circulating enzyme produced by the placenta, degrades oxytocin. The amount of oxytocin being metabolized by placental oxytocinase is equal to the amount infused.
During gestation. the oxytocinase activity increases simultaneously with increases in metabolic clearance of oxytocin. 6 0.,61 Myometrial responses to oxytocin levels vary according to status of the cervix, uterine sensitivity, variability in oxytocin clearance rate, duration of pregnancy and preexisting uterine contractions. 52 Myometrial responsiveness to oxytocin begins at 20 weeks of gestation and increases thereafter throughout the pregnancy with its peak response before initiation of labor. The peak coinddes with a time when oxytocin receptors are at maximum levels. It appears that oxytocin stimulates production and release of arachidonic acid and prostaglandin F2 a by decidua and results in uterine contractions. 53 Pulsatile infusion has been used for induction of labor as it closely simulates the pulsatile release of the hormone from the posterior pituitary gland during spontaneous labor. It is given every 8 minutes beginning at a dose of 1 mu and doubling the dose every 24 minutes until a uterine contraction is obtained.....' It is believed that oxytocin binds to myometrial receptors, leaving them temporarily unavailable for binding additional, continuously infused oxytocin. This method is more physiologic, requires less oxytocin than continuous infusion, and is beneficial in patients in whom a lower fiuid volume is desired. However, the equipment necessary to provide pulsatile oxytocin infusion is not readily available to most practicing physicians, and this technique remains largely investigational...."
Dosage and Administration Synthetic oxytocin (pitocin) is available in an

Continuous intravenous infusion is the most
widely used method. The solution used usually contains 10 usp units (1 mI) synthetic oxytocin added to 1000 mI ofisotonic electrolyte solution. increase. It is shown that following intravenous infusion of oxytocin, uterine response occurs within 3-5 minutes, and a steady plasma concentration is reached in 40 minutes. 53 Some investigators recommend low doses (2-4 mu/min. range), which mimic the normal physiologic pattern of endogenous oxytocin release. Others favor a high (pharmacologic) dose (6 mU/min) of oxytocin for the active management of labor. The maximum dose should not exceed 40 mU/min in any given regimen. Table 3 summarizes various oxytocin dosages and optimal intervals.
Studies have shown that both low dose (physiologic) and high dose (pharmacologic) oxytocin regimens are equally successful in establishing adequate labor.w-72 It is recommended that an oxytocin dose should be used to produce uterine contractions every 2 to 3 minutes and lasting 60 to 90 seconds with 50 to 60 mmHg intrauterine pressure. Hauth et al showed that most patients achieve normal labor with 3to Suterine contractions with SO to 100 mmHg • Medical personnel should be able to identify and manage oxytocin complications and/or perform a cesarean delivery when necessary.
• A written protocol for oxytocin administration approved by the medical staffshould be available in the labor and delivery unit.
• Prior to infusion, the patient should be informed about potential risks and benefits of oxytocin infusion and an informed consent should be obtained.
• Oxytocin infusion is best controlled by a constant infusion pump. • Once labor progresses and the intensity of uterine contractions increases, the oxytocin infusion rate should be reduced or the infusion discontinued to avoid hyperstimulation. • Initial1y, uterine activity and fetal heart rate monitoring are done with external devices. whenever possible. amniotomy. an intrauterine pressure catheter, and a fetal scalp electrode are used to assess uterine contractions, to evaluate fetal heart rate tracing, and to regulate oxytocin infusion rate.
• During active labor, cervical dilatation, effacement, descent ofthe presenting part and intensity of contractions should be recorded. A graphic documentation using Friedman's labor curve would be most helpful in assessing progress of labor. 75 
Comp1lcations ofOXytocin Infusion a. Uterine Hyperstimulation
Uterine hyperstimulation is defined as uterine contractions more often than every 2 minutes and lasting longer than 90 seconds with or without fetal heart changes. This hyperstimulation refers to either frequent uterine activity or increased myometrial tone, which may result in uteroplacental hypoperfusion and fetal hypoxia. This occurs when the uterine resting tone exceeds 20 mmHg. Excessive uterine contractions may also lead to uterine rupture or abruptio placentae. The mechanism of hyperstimulation may be related to overdosage of oxytocin, increased uterine sensitivity to oxytocin. changes in receptor-binding kinetics or oxytocininduced prostaglandin production." Uterine hyperstimulation may also be related to increased endogenous oxytocin production by maternal or fetal comparbnents. i1 Measures necessary for management of uterine hyperstimulation include changing the patient's position to the left: side, administration of oxygen and more intravenous fluid., and decreasing or discontinuing oxytocin infusion. Ifhyperstimulation persists after oxytocin is stopped and a nonreassuring fetal heart rate pattern occurs, intrauterine fetal resuscitation with terbutaline 0.125 mg given intravenously or by subcutaneous injection should be considered for rapid resolution of hyperstimulation.
b. Water Intoxication
Due to its structural and functional similarity to the antidiuretic hormone. oxytocin given in large doses can result in water intoxication that leads to hyponatremia, confusion, conwlsion, coma, congestive heart failure. and death. Water intoxication can occur with a large dose of oxytocin (40 mu/min or more) given for prolonged periods. Strict adherence to judicious use of oxytocin and close monitoring of fluid intake and output prevents this serious complication. Whenever patients require a large oxytocin infusion rate, the possibility of abdominal (extrauterine) pregnancy or the presence of placental sulfatase defiCiency should be considered. 
d. Other Complications
Abruptio placentae, precipitous delivery, postpartum uterine atony and hemorrhage, and neonatal hyperbilirubinemia are other complications that can occur. II Amniotic fluid embolism is a very rare complic.ation of oxytocin infusion. It is more apt to happen when oxytocin is used to induce labor for fetal demise. Hypotension occurs when oxytocin is used intravenously in bolus form.
Prostaglandins
The second category of drugs used in medical induction of labor is prostaglandins. A Bishop score of 4 or less denotes an unfavorable cervix and is an indication for cervical ripening. The most commonly used prostaglandins for cervical ripening and induction of labor are prostaglandin E2, which contains dinoprostone as the naturally occurring form ofPGE2, and prostaglandin El, or misoprostol, a synthetic PGEI analog. Two forms of prostaglandin E2 are available for clinical use: PGE2 gel (Prepidil) and PGE2 vaginal insert (Cervidil). Prostaglandin E2 preparations are used locally intravaginally or intracervically. Several randomized prospective studies have shown that PGE2 is more effective than oxytocin infusion for promoting vaginal birth."" Histologic changes following local administration of PGE2 in the cervix include a dissolution of collagen bundles and an increase in tissue water content, which leads to cervical softening, effacement, and dilatation. 86 The Cervidil insert should be removed by pulling its cord after 12 hours or when active labor begins or uterine hyperstimulation occurs. The cervidil vaginal insert has an advantage over Prepidil gel in that it can be easily removed should uterine hyperstimulation occur. A safe time interval between PGE2 insertion and oxytocin initiation is not established.
Because PGE2 potentiates the effect of oxytocin, Cervidil must be removed before oxytocin infusion is started. uterine activity and the fetal heart rate should be monitored.
Efficacy and safety of Cervidil have been shown in prospective double-blind controlled trials. Furthermore, it has been demonstrated that use of Cervidil decreases the need for oxytocin. 91 ,n Cervidil is well tolerated. In placebo controlled trials, the incidence ofmaternal adverse effects, i.e. fever, nausea, vomiting, diarrhea, and abdominal pain, were noted in fewer than 1% of patients who received Cervidil. The incidence of uterine hyperstimulation with fetal distress was 2.8%, and hyperstimulation without fetal distress was 4.8%. Fetal distress with- Although the FDA has not approved misoprostol for cervical ripening, it has received increased attention as a highly effective cervical ripening agent.
This medication has the advantage of being inexpensive, easy to store, and stable at room temperature, while prostaglandin E2 gel is an unstable compound that must be refrigerated to preserve its potency.
The cost of a 100 mcg tablet of misoprostol is estimated at approximately $2, whereas the cost of one Cervidil PGE2 insert is $175.24 at our institution.
Indications and Contraindications:
Investigational protocols recommend the follow- 25 mcg rnisoprostol every 4 hours (for a maximum of 8 doses). Following the initial rnisoprostol dosing, subsequent doses can be repeated except when the patient develops uterine contractile abnormalities (tachysystole, hypersystole, hyperstimulation) or nonreassuring fetal heart rate patterns.
• Tachysystole is defined as 6 or more uterine contractions in 10 minutes for 2 consecutive 10-minute periods.
• Hypersystole is defined as a single contraction of at least two minutes in duration.
• Uterine hyperstimulation is defined as tachysystole or hypersystole associated with nonreassuring fetal heart rate pattern.
• A nonreassuring fetal heart rate pattern includes persistent or recurring episodes of severe variable decelerations, late decelerations, or prolonged fetal bradycardia, or a combination of decreased beat-to-beat variability and a decelerative pattern.
It is also recommended that subsequent misoprostol doses should not be given when the cervix is >3 cm dilated and 10096 effaced or when spontaneous JIMA: Volume 39, 2007 -Page 22 rupture of the membranes occurs. Following cervical dilatation of >3 ern, uterine contractions should be maintained using oxytocin infusion. The incidence of tachysystole is reduced by 5096 when the 25 meg instead of the 50 meg misoprostol regimen is used for cervical ripening.
Patients receiving misoprostol should be continuously monitored for uterine activity and fetal heart rate. Adherence to a low-dose misoprostol regimen will probably reduce the incidence of uterine hyperstimulation and subsequent abnormal fetal heart rate pattern and further reduce potential need for cesarean delivery. Mifepristone This steroid, an anti-Progestin agent, is also reported to result in cervical changes and increased uterine activity.111-4 A French report on RU-486 for induction of term pregnancy showed that 200 mg of RU-486 daily for two days resulted in a higher incidence ofspontaneous labor than when patients were not treated with this agent. 1 l!i However, there are not enough studies in the United States to suggest use of mifepristone for cervical ripening and induction oflabor.
Oral AdministrrztiDn ofMisoprostol
Relaxin
Human relaxin is a polypeptide hormone produced by the corpus luteum, the decidua, and the chorion. 
